biostudies-literatureUnknown13(14)Senok ARapid pathogen identification is key to the proper management of patients with bloodstream infections (BSIs), especially in the intensive care setting. This multicentre study compared the time to pathogen identification results in 185 patients admitted to intensive care with a confirmed BSI, using conventional methods (<i>n</i> = 99 patients) and upon implementation of the BIOFIRE^® Blood Culture Identification 2 (BCID2) Panel, a rapid molecular test allowing for the simultaneous identification of 43 BSI-related nucleic acids targets (<i>n</i> = 86 patients). The median time to result informing optimal antibiotic therapy was significantly shorter following the implementation of the BCID2 Panel (92 vs. 28 h pre vs. post BCID2 implementation; <i>p</i> < 0.0001). BCID2 usage in addiDiagnostics (Basel, Switzerland)2433https://www.ebi.ac.uk/biostudies/studies/S-EPMC10378530biostudies-literatureClinical Impact of the BIOFIRE Blood Culture Identification 2 Panel in Adult Patients with Bloodstream Infection: A Multicentre Observational Study in the United Arab Emirates.PMC10378530Celiloglu HOlowoyeye VRizvi IHBashiri SMohmed AADabal LAElimam MAESalama BHabous MAhmed HAlmaazmi NBahaaldin OSenok AAlfaresi MPowell MfalseClinical Impact of the BIOFIRE Blood Culture Identification 2 Panel in Adult Patients with Bloodstream Infection: A Multicentre Observational Study in the United Arab Emirates.Rapid pathogen identification is key to the proper management of patients with bloodstream infections (BSIs), especially in the intensive care setting. This multicentre study compared the time to pathogen identification results in 185 patients admitted to intensive care with a confirmed BSI, using conventional methods (<i>n</i> = 99 patients) and upon implementation of the BIOFIRE^® Blood Culture Identification 2 (BCID2) Panel, a rapid molecular test allowing for the simultaneous identification of 43 BSI-related nucleic acids targets (<i>n</i> = 86 patients). The median time to result informing optimal antibiotic therapy was significantly shorter following the implementation of the BCID2 Panel (92 vs. 28 h pre vs. post BCID2 implementation; <i>p</i> < 0.0001). BCID2 usage in addi2023-01-01T00:00:00Z2023 Jul2025-04-22T00:59:37.046Z2025-04-05T19:47:14.654ZS-EPMC103785303751017710.3390/diagnostics13142433